Compare CJC-1295 (evidence D) and Tesamorelin (evidence A) on mechanism, clinical status, safety, and dosing.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) originally developed by ConjuChem Technologies for HIV-associated lipodystrophy.…
Tesamorelin (tesamorelin acetate) is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH) and the only FDA-approved medication…
Full profiles: CJC-1295, Tesamorelin.